STLN — Starling Oncology, Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1799191 ·
Last close
$3.40
Market Cap
$346.51M
52W High
$7.13
52W Low
$2.32
ADV30
3,713,768
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 169,767,000 30,670,000 -2,982,000 -15,748,000 187,773,000 36,895,000 225,128,000
Jun 2026 161,282,000 27,165,000 -4,616,000 -9,789,000 178,233,000 41,094,000 203,147,000
Mar 2026 147,441,000 23,315,000 -6,513,000 -2,492,000 168,230,000 30,280,000 184,515,000
Dec 2025 141,957,000 22,765,000 -6,907,000 -7,508,000 164,656,000 33,565,000 180,376,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$328,000
Investing CF
$-3,614,000
Financing CF
$14,088,000
CapEx
$-3,614,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.30
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-283,700,000
Inventory
$20,011,000
Receivables
$66,709,000
ST Investments
—
EBIT TTM
$-28,664,000
Pretax Income TTM
$-36,293,000
Interest Exp TTM
$7,629,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$620,446,976
EBITDA
$-14,410,000
Free Cash Flow
$29,539,624
Enterprise Value
$435,067,520
Total Cash
$36,895,000
Total Debt
$102,755,000
Shares Out
101,916,115
Trailing EPS
$-0.28
Book Value
$-0.37
ROE
—
ROA
-7.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 502,729,000 -36,083,000 -60,606,000 164,656,000 180,376,000 -15,720,000 -24,587,000
Dec 2024 393,412,000 -60,118,000 -64,663,000 172,717,000 169,128,000 3,589,000 -26,538,000
Dec 2023 324,239,000 -60,151,000 -83,068,000 209,240,000 152,215,000 57,025,000 -36,315,000
Dec 2022 252,483,000 -72,007,000 152,000 261,665,000 138,490,000 123,175,000 -61,756,000

TTM Snapshot

Revenues TTM
$587,244,000
NetIncome TTM
$-36,293,000
OpCashFlow TTM
—
Assets (Latest)
$178,233,000
Forward EPS
—

Max Pain — expiry 2027-02-19

max pain strike: $4.00 · spot: $3.20 · call oi: 19,659 · put oi: 1,417
Expected Move to 2027-02-19: ±$1.00 (31.25%) — implied range $2.20 – $4.20 · ATM straddle on $3.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
VMD VIEMED HEALTHCARE, INC. $343.69M $9.07 —
YDES YD Bio Ltd $335.03M $4.73 —
CYH COMMUNITY HEALTH SYSTEMS INC $284.87M $2.02 —
DFPH Starling Oncology, Inc. $436.37M $2.01 —
MCTA Charming Medical Ltd $445.55M $29.35 —

News headlines (Yahoo Finance, 1h cache)

Oncology Institute Q3 Earnings Call Highlights
2026-11-06 14:14 · Yahoo
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates
2026-11-05 21:45 · Yahoo
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
2026-11-05 21:06 · Yahoo
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
2026-10-26 13:00 · Yahoo
Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views
2026-10-15 23:22 · Yahoo
Starling Oncology to Participate in Wells Fargo Healthcare Conference
2026-08-24 13:00 · Yahoo
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
2026-08-06 23:10 · Yahoo
Geron (GERN) Reports Break-Even Earnings for Q3
2026-11-04 12:55 · Yahoo
Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates
2026-11-03 21:50 · Yahoo
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
2026-10-01 20:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.